Breast Cancer Clinical Trial
— SMARTGOALOfficial title:
Self-monitoring Activity: a Randomized Trial of Game-oriented Applications (SMARTGOAL)
| NCT number | NCT02341235 |
| Other study ID # | 14-0376 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | February 2015 |
| Est. completion date | June 30, 2021 |
| Verified date | August 2021 |
| Source | The University of Texas Medical Branch, Galveston |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to compare an enhanced intervention that includes narrative and game components to a standard intervention that only targets self-monitoring. These approaches will be tested among postmenopausal breast cancer survivors who are sedentary and overweight.
| Status | Completed |
| Enrollment | 90 |
| Est. completion date | June 30, 2021 |
| Est. primary completion date | June 30, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 45 Years to 75 Years |
| Eligibility | Inclusion Criteria: 1. Age between 45 and 75 years old 2. Report a breast cancer diagnosis no more than 10 years prior to enrollment 3. Cessation of menses for 12 months or more 4. Able to read and understand English 5. Able to read words in standard applications on a mobile device 3-4" large 6. Able to walk for exercise 7. Able to find transportation to the study location 8. Willing to use a mobile device provided by the study to participate (or to use one of their own) 9. Willing to be randomized to either group Exclusion Criteria: 1. Currently pregnant or nursing 2. Surgery in the past six months 3. Chemotherapy or radiation treatment in the past six months 4. Evidence of disease recurrence 5. Participant is active (90 minutes of moderate-vigorous intensity activity per week or more) 6. BMI is under 25 kg/m2 or over 35 kg/m2 7. Report a heart condition, chest pain during periods of activity or rest, loss of consciousness, etc. on the Physical Activity Readiness Questionnaire (PAR-Q), unless cleared by their physician 8. Participant reports hospitalization within the past year due to psychiatric problem(s) 9. Report current symptoms of alcohol or substance dependence 10. Plans to move away from the Galveston-Houston area or to be out of town for more than 1 week during the study period 11. Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months 12. Report a history of severe orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., severe arthritis, leg amputations, etc.) 13. Clinical judgment concerning safety 14. Lost more than 5% body weight in the previous 6 months 15. Currently participating in a physical activity or weight loss program 16. Current smoker 17. Participant already uses an electronic activity monitor (we will ask them to stop) 18. Another member of the household is a participant or staff member on this trial |
| Country | Name | City | State |
|---|---|---|---|
| United States | The University of Texas Medical Branch | Galveston | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| The University of Texas Medical Branch, Galveston | American Cancer Society, Inc. |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Maintenance of physical activity from 6 months to 1 year | Minutes of moderate-vigorous physical activity measured over a 7 day period | 6 months | |
| Other | Maintenance of physical fitness from 6 months to 1 year, measured by a 6 minute walk test | We will use a 6 minute walk test to measure fitness | 6 months | |
| Other | Maintenance of physical function from 6 months to 1 year, measured by the Senior Fitness Test | We will use the Senior Fitness Test to measure physical function | 6 months | |
| Other | Change in sleep from 6 months to 1 year, measured by a computerized PROMIS measure | We will use a computerized PROMIS measure | 6 months | |
| Other | Change in weight from 6 months to 1 year | Weight will be measured using a calibrated scale | 6 months | |
| Other | Adherence, measured by objective measures to investigate adherence to study protocols (game usage, monitor usage, phone calls completed, assessments attended, etc.) | We will use objective measures to investigate adherence to study protocols (game usage, monitor usage, phone calls completed, assessments attended, etc.) | 1 year | |
| Other | Number of participants who report adverse events | We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. | 1 year | |
| Other | Change in anxiety from 6 months to 1 year, measured by a computerized PROMIS measure | We will use a computerized PROMIS measure | 6 months | |
| Other | Change in depression from 6 months to 1 year, measured by a computerized PROMIS measure | We will use a computerized PROMIS measure specific to cancer patients/survivors | 6 months | |
| Other | Change in fatigue from baseline to 6 months, measured by a computerized PROMIS measure | We will use a computerized PROMIS measure specific to cancer patients/survivors | 6 months | |
| Other | Change in quality of life from 6 months to 1 year as measured by Functional Assessment of Cancer Therapy - Breast measure | We will use the Functional Assessment of Cancer Therapy - Breast measure | 6 months | |
| Other | Change in motivation from 6 months to 1 year, measured by autonomous motivation specific to physical activity | Behavioral Regulation in Exercise Questionnaire-2 will be used | 6 months | |
| Other | Acceptability, measured using self-report measures of usability and liking of the apps | Participants will report their perceptions of app usability and acceptability in the 6 month questionnaire | 6 months | |
| Other | Play experience, measured using the play experience questionnaire | Participants will self-report their perceptions of the playfulness of the intervention apps | Measured at 3 months | |
| Other | Change in exercise identity from baseline to 6 months, measured using the Exercise Identity Scale | We will use the Exercise Identity Scale | 6 months | |
| Other | Narrative engagement (measured in narrative group only), measured using the Narrative Engagement Scale | We will measure the extent to which participants in the narrative group felt narratively engaged in the game's storyline | Measured at 3 months | |
| Other | Character identification (measured in narrative group only), measured using the Player Identification Scale | We will measure the extent to which participants in the narrative group felt like they identified with their game character | Measured at 3 months | |
| Primary | Change in physical activity from baseline to 6 month | Minutes of moderate-vigorous physical activity over a 7 day period | 6 months | |
| Secondary | Change in physical fitness from baseline to 6 months, as measured by 6 minute walk test | We will use a 6 minute walk test to measure fitness | 6 months | |
| Secondary | Change in physical function from baseline to 6 months as measured by the Senior Fitness Test | We will use the Senior Fitness Test to measure physical function | 6 months | |
| Secondary | Change in weight from baseline to 6 months | We will measure weight using a calibrated scale | 6 months | |
| Secondary | Change in quality of life from baseline to 6 months as measured by Functional Assessment of Cancer Therapy - Breast measure | We will use the Functional Assessment of Cancer Therapy - Breast measure | 6 months | |
| Secondary | Change in depression from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors | We will use a computerized PROMIS measure specific to cancer patients/survivors | 6 months | |
| Secondary | Change in fatigue from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors | We will use a computerized PROMIS measure specific to cancer patients/survivors | 6 months | |
| Secondary | Change in anxiety from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors | We will use a computerized PROMIS measure specific to cancer patients/survivors | 6 months | |
| Secondary | Change in sleep from baseline to 6 months, measured by a computerized PROMIS measure | We will use a computerized PROMIS measure | 6 months | |
| Secondary | Change in motivation from baseline to 6 months, measured by autonomous motivation specific to physical activity | Behavioral Regulation in Exercise Questionnaire-2 will be used | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |